These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 5475414)
61. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain. Bacopoulos NG; Bustos G; Redmond DE; Roth RH J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729 [No Abstract] [Full Text] [Related]
62. [Delayed-action preparation therapy as a possibility in social rehabilitation]. Haring C Med Welt; 1972 Aug; 23(35):1140-3. PubMed ID: 5075530 [No Abstract] [Full Text] [Related]
67. [Fluphenazine enanthate]. Canton CE Rev Bras Med; 1966 Sep; 23(9):627-32. PubMed ID: 5998053 [No Abstract] [Full Text] [Related]
68. [Clinical and electroencephalographic study of neuroleptic dibenzothiazepine derivative: HF 21.59]. Deniker P; Verdeaux GJ; Ginestet D; Péron-Magnan P Rev Neurol (Paris); 1965 Sep; 113(3):264-6. PubMed ID: 5853425 [No Abstract] [Full Text] [Related]
69. Relationship between fluphenazine plasma concentration and electroencephalographic alterations. Robert TA; Daigneault EA; Hagardorn AN Commun Psychopharmacol; 1978; 2(6):467-74. PubMed ID: 747913 [No Abstract] [Full Text] [Related]
70. [Action of fluphenazine and benzperidol on psychologic tests (Rorschach) of psychotic patients]. Haumonte MT; Wurtz D; Brenet ; Jacquot MP Ann Med Psychol (Paris); 1970 Jan; 1(1):121-34. PubMed ID: 5421305 [No Abstract] [Full Text] [Related]
71. ELECTROENCEPHALOGRAPHIC MANIFESTATIONS ASSOCIATED WITH PSYCHOTIC ILLNESS: PENTOTHAL ACTIVATION TECHNIQUE AND PHARMACOLOGIC INTERRELATIONSHIPS. GOLDMAN D Compr Psychiatry; 1964 Apr; 5():80-92. PubMed ID: 14138291 [No Abstract] [Full Text] [Related]
72. A useful drug. Anderson HW J Tenn Med Assoc; 1970 Mar; 63(3):204-5. PubMed ID: 5417715 [No Abstract] [Full Text] [Related]
73. [Correlation between electroencephalographic and clinical modifications in schizophrenia]. BAGALEI-EKELOVA EM; SHMEL'KIN DG Nevropatol Psikhiatriia; 1951; 20(4):48-51. PubMed ID: 14882413 [No Abstract] [Full Text] [Related]
74. [Contribution to the electroencephalographic study of schizophrenia]. CENACCHI G; ESCALAR G Minerva Med; 1958 Oct; 49(80):3805-8. PubMed ID: 13612961 [No Abstract] [Full Text] [Related]
75. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate]. Auch W Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981 [No Abstract] [Full Text] [Related]
76. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses. Roose K Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558 [TBL] [Abstract][Full Text] [Related]
77. [Clinical and biological effects of fluphénazine décanoate. 35 cases]. Borenstein P; Dumaine A; Cujo P Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413 [No Abstract] [Full Text] [Related]
78. The use of depot neuroleptics: clinical experience in the United States. Kane JM J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987 [TBL] [Abstract][Full Text] [Related]
79. [Electroencephalographic effects of fluphonazine decanoate]. Borenstein P; Cujo P; Dumaine A Ann Med Psychol (Paris); 1970 Jul; 2(2):273-5. PubMed ID: 5475414 [No Abstract] [Full Text] [Related]